Progyny, Inc. (NASDAQ:PGNY) Q3 2022 Earnings Conference Call November 3, 2022 4:45 PM ET
Company Participants
James Hart - VP, IR
Peter Anevski - CEO
Mark Livingston - CFO
Conference Call Participants
Anne Samuel - JPMorgan
Jailendra Singh - Truist Securities
Scott Schoenhaus - KeyBanc
Glen Santangelo - Jefferies
Sarah James - Barclays
Stephanie Davis - SVB Securities
Deb Weerasuriya - Berenberg
Operator
Good afternoon, ladies and gentlemen, and welcome to the Progyny, Inc. Third Quarter 2022 Earnings Call. At this time, all participants have been placed on a listen-only mode and we will open the floor for your questions and comments after the presentation.
It is now my pleasure to turn the floor over to your host, James Hart. Sir, the floor is yours.
James Hart
Thank you, Matthew, and good afternoon, everyone. Welcome to our third quarter conference call. With me today are Peter Anevski, CEO of Progyny; Michael Sturmer President; and Mark Livingston, CFO.
We will begin with some prepared remarks before we open the call for your questions. Before we begin, I'd like to remind you that our comments and responses to your questions on the management's view as of today only and will include statements related to our financial outlook for both the third quarter and full year 2022 and the assumptions and drivers underlying such guidance, including the impact of our sales season, client launches and our expected utilization rate and mix, our anticipated number of clients in covered lives for 2023, the impact of COVID-19 including variants, on our business, clients, member activity and industry operations, the impact of any shortages or disruptions in the pharmacy medication supply chain on our business and our financial condition, our ability to acquire new clients and retain and upsell existing clients; our market opportunity, size and expectation of long-term growth our plans for the expansion of our business, including expansion into other markets and services offered, our business performance, industry outlook, strategy, future investments, plans and objectives, which are forward-looking statements under the federal securities laws.
Actual results may differ materially from those contained in or implied by these forward-looking statements due to risks and content associated with our business as well as other important factors.
For a discussion of the material risks, uncertainties and other important factors that could impact our actual results, please refer to our SEC filings and today's press release, which can be found on our Investor Relations website.